To speed up the treatment of coronavirus patients, the Drug Controller General of India (DCGI) on Friday approved the emergency use of Zydus Cadila's drug 'Virafin'. The drug can be used for treating moderate COVID-19 infections in patients above 18 years of age. The company has said that 91.15 per cent of patients treated with the drug were RT-PCR negative by day seven. The treatment significantly reduces the hours for supplemental oxygen in coronavirus patients. When administered early on during COVID-19, Virafin will help patients recover faster and avoid much of the complications.

Source: dna April 23, 2021 11:03 UTC